Literature DB >> 1640177

Listericidal and nonlistericidal mouse macrophages differ in complement receptor type 3-mediated phagocytosis of L. monocytogenes and in preventing escape of the bacteria into the cytoplasm.

D A Drevets1, B P Canono, P A Campbell.   

Abstract

Listeria monocytogenes is a facultative intracellular bacterium that escapes phagocytic vesicles and replicates in the cytoplasm, where it becomes coated with F-actin. Macrophages, important anti-Listeria effector cells, are heterogeneous in their ability to kill Listeria. Complement receptor type 3 (CR3) mediates most phagocytosis of Listeria by listericidal macrophages. Experiments described here tested whether nonlistericidal macrophages also phagocytosed Listeria through CR3 and whether the ability of Listeria to escape into the cytoplasm correlated with lack of listericidal activity. We show here that CR3 mediated an average of 66% of the phagocytosis of serum-opsonized Listeria by listericidal peptone-elicited macrophages but only 35% by nonlistericidal thioglycolate-elicited macrophages. In thioglycolate-elicited macrophages, most Listeria were cytoplasmic and actin coated, whereas in peptone-elicited macrophages most were retained in the phagosome. These results indicate that listericidal and nonlistericidal macrophages phagocytose Listeria through different receptors and that nonlistericidal macrophages allow Listeria to escape into the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640177     DOI: 10.1002/jlb.52.1.70

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  20 in total

1.  A new assay to monitor the degranulation process in phagocytizing human neutrophils.

Authors:  Violetta Borelli; Maria Giovanna Perrotta; Francesca Vita; Maria Rosa Soranzo; Giuliano Zabucchi
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

Review 2.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

3.  Monocytes of individual human subjects display heterogeneous bacterial uptake and antilisterial activity.

Authors:  G Zerlauth; H E Chehadeh; E Maier; Z Schaff; M M Eibl; J W Mannhalter
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Expression of the inlAB operon by Listeria monocytogenes is not required for entry into hepatic cells in vivo.

Authors:  S H Gregory; A J Sagnimeni; E J Wing
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activation.

Authors:  Masashi Emoto; Tomomi Yoshida; Toshio Fukuda; Ikuo Kawamura; Masao Mitsuyama; Eiji Kita; Robert Hurwitz; Stefan H E Kaufmann; Yoshiko Emoto
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

Review 6.  Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection.

Authors:  Daniel G Calame; Stacey L Mueller-Ortiz; Rick A Wetsel
Journal:  Immunobiology       Date:  2016-07-16       Impact factor: 3.144

7.  Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice.

Authors:  H W Rogers; E R Unanue
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Characterization of Listeria monocytogenes pathogenesis in a strain expressing perfringolysin O in place of listeriolysin O.

Authors:  S Jones; D A Portnoy
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Gentamicin kills intracellular Listeria monocytogenes.

Authors:  D A Drevets; B P Canono; P J Leenen; P A Campbell
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Listeria monocytogenes infects human endothelial cells by two distinct mechanisms.

Authors:  D A Drevets; R T Sawyer; T A Potter; P A Campbell
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.